News

The Latest

Hormonal Contraception Does Not Increase HIV Risk, Study Finds

No meaningful difference was found in either injectable or implant birth control when compared to an IUD.

By Sony Salzman

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.

By Barbara Jungwirth and Myles Helfand

HIV Advocacy Group Spars With Express Scripts Over HIV Drug Formulary Changes

Starting July 1, some HIV meds that are widely used will be excluded from their list.

By Sony Salzman

HIV Testing Among Black Gay and Bisexual Men Remains 'Suboptimal,' Study Finds

Black men who have sex with men test in high numbers over a lifetime, but not frequently or recently.

By Stephen Hicks

Government Panel Finds PrEP Is Effective, Must Be Available Free of Cost to Patients

The US Preventive Services Task Force released its final ruling in JAMA.

By Kenyon Farrow

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

By Barbara Jungwirth and Myles Helfand

CDC Study Reinforces the Importance of Annual STI Testing Among MSM

Rectal and throat tests matter too, and providers should be recommending them.

By Sony Salzman

This Week in HIV Research: Matters of the Heart

May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.

By Barbara Jungwirth and Myles Helfand

FDA Approves First Throat and Rectal Tests for Detecting Chlamydia and Gonorrhea

These two tests make it easier to diagnose sexually transmitted infections that often go untreated.

By Stephen Hicks